Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · May 14, 2024

Effect of Combination Treatment With GLP-1 Receptor Agonists and SGLT-2 Inhibitors on Incidence of Cardiovascular and Serious Renal Events

BMJ: British Medical Journal

 

Additional Info

Disclosure statements are available on the authors' profiles:

BMJ: British Medical Journal
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
BMJ 2024 Apr 25;[EPub Ahead of Print], N Simms-Williams, N Treves, H Yin, S Lu, O Yu, R Pradhan, C Renoux, S Suissa, L Azoulay

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading